Upper respiratory tract infections have minimal impact on neffy's pharmacokinetics or pharmacodynamics

被引：3

作者：

Oppenheimer, John ^{[1
]}

Casale, Thomas B. ^{[2
]}

Camargo, Carlos A. ^{[3
]}

Fleischer, David M. ^{[4
]}

Bernstein, David ^{[5
,6
]}

Lowenthal, Richard ^{[7
]}

Tanimoto, Sarina ^{[7
]}

机构：

[1] UMDNJ Rutgers Univ, Sch Med, Newark, NJ USA

[2] Univ S Florida, Morsani Coll Med, Tampa, FL USA

[3] Harvard Med Sch, Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA USA

[4] Univ Colorado, Sch Med, Aurora, CO USA

[5] Univ Cincinnati, Div Immunol & Allergy, Coll Med, Cincinnati, OH USA

[6] Bernstein Clin Res Ctr, Cincinnati, OH USA

[7] ARS Pharmaceut, San Diego, CA USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2024年 / 12卷 / 06期

关键词：

D O I：

10.1016/j.jaip.2024.02.038

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1640 / 1643.e2

页数：6

共 50 条

[1] Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections
Drusano, GL
Craig, WA
JOURNAL OF CHEMOTHERAPY, 1997, 9 : 38 - 44
[2] Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections
Andes, D
Anon, J
Jacobs, MR
Craig, WA
CLINICS IN LABORATORY MEDICINE, 2004, 24 (02) : 477 - +
[3] Pharmacokinetics and pharmacodynamics of newer fluoroquinolones in patients with lower respiratory tract infections
Kontou, Paschalina
Chatzika, Kalliopi
Manika, Katerina
Pitsiou, Georgia
Sionidou, Maria
Kioumis, Ioannis
EUROPEAN RESPIRATORY JOURNAL, 2012, 40
[4] EFFECT OF UPPER RESPIRATORY TRACT INFECTION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRANASAL EPINEPHRINE
Oppenheimer, J.
Casale, T.
Camargo, C.
Fleischer, D.
Bernstein, D.
Lowenthal, R.
Tanimoto, S.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S20 - S20
[5] Pharmacokinetics and pharmacodynamics of fluoroquinolones in the respiratory tract
Wise, R
Honeybourne, D
EUROPEAN RESPIRATORY JOURNAL, 1999, 14 (01) : 221 - 229
[6] Epidemiology and social impact of infections of the upper respiratory tract
Passali, D.
JOURNAL OF CHEMOTHERAPY, 2006, 18 : 54 - 55
[7] Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of community-acquired respiratory tract infections
Calbo, E
Garau, J
RESPIRATION, 2005, 72 (06) : 561 - 571
[8] Population pharmacokinetics and pharmacodynamics of sitafloxacin in patients with community-acquired respiratory tract infections
Tanigawara, Yusuke
Kaku, Mitsuo
Totsuka, Kyoichi
Tsuge, Hiroyuki
Saito, Atsushi
JOURNAL OF INFECTION AND CHEMOTHERAPY, 2013, 19 (05) : 858 - 866
[9] Population pharmacokinetics and pharmacodynamics of garenoxacin in patients with community-acquired respiratory tract infections
Van Wart, S
Phillips, L
Ludwig, EA
Russo, R
Gajjar, DA
Bello, A
Ambrose, PG
Costanzo, C
Grasela, TH
Echols, R
Grasela, DM
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) : 4766 - 4777
[10] RESPIRATORY TRACT INFECTIONS IN CHILDREN .A. UPPER RESPIRATORY TRACT INFECTIONS
EICHENWALD, HF
CANADIAN MEDICAL ASSOCIATION JOURNAL, 1973, 109 (07) : 622 - 624

← 1 2 3 4 5 →